Chapter 1. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By Component

6.1. Whole Exome Sequencing

6.2. Targeted Sequencing & Resequencing Centrifuges

6.3. Whole Genome Sequencing

Chapter 7. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By Work Flow

7.1. Sequencing

7.2. Data Analysis

7.3. Pre-Sequencing

Chapter 8. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By Application

8.1. Companion Diagnostics

8.2. Screening

8.3. Others

Chapter 9. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By End User

9.1. Clinics

9.2. Laboratories

9.3. Hospitals

Chapter 10. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By Region

10.1. North America

10.2. Europe

10.3. Asia-P2acific

10.4. Latin America

10.5. The Middle East

10.6. Africa

Chapter 11. CLINICAL ONCOLOGY NEXT GENERATION SEQUENCING MARKET – By Companies

11.1. Companies 1

11.2. Companies 2

11.3. Companies 3 

11.4. Companies 4

11.5. Companies 5

11.6. Companies 6

11.7. Companies 7

11.8. Companies 8

11.9. Companies 9

1110. Companies 10